Chel Hun Choi Selected Research

Chel Hun Choi Research Topics

Disease

91	Neoplasms (Cancer) 03/2024 - 11/2005
60	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024 - 04/2006
35	Ovarian Neoplasms (Ovarian Cancer) 04/2024 - 03/2006
25	Ovarian Epithelial Carcinoma 01/2024 - 08/2009
21	Carcinoma (Carcinomatosis) 01/2024 - 11/2005
18	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2010
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 11/2005
13	Adenocarcinoma 12/2022 - 12/2010
11	Endometrial Neoplasms (Endometrial Cancer) 01/2024 - 03/2011
9	Lymphatic Metastasis 01/2018 - 09/2007
5	Postoperative Pain 01/2023 - 09/2010
5	Leiomyoma (Uterine Fibroids) 07/2021 - 06/2011
5	Wounds and Injuries (Trauma) 03/2013 - 07/2009
4	Carcinogenesis 01/2020 - 07/2006
4	Residual Neoplasm 03/2019 - 10/2008
4	Myoma 04/2015 - 01/2010
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 07/2010
3	Disease Progression 12/2023 - 01/2020
2	Anemia 04/2024 - 01/2014
2	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2017
2	Pain (Aches) 01/2023 - 10/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2017
2	Adenomyosis 04/2015 - 01/2010
1	Thromboembolism 04/2024

Drug/Important Bio-Agent (IBA)

16	PlatinumIBA 01/2024 - 04/2011
16	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2006
10	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2012
10	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 07/2006
9	ParaffinIBA 07/2017 - 11/2005
8	AntigensIBA 01/2021 - 07/2010
8	Small Interfering RNA (siRNA)IBA 01/2020 - 08/2010
8	Formaldehyde (Formol)FDA Link 07/2017 - 11/2005
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 05/2014
6	durvalumabIBA 01/2024 - 11/2019
5	olaparibIBA 12/2023 - 11/2019
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 10/2008
5	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 08/2009
4	Bevacizumab (Avastin)FDA Link 12/2023 - 10/2020
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 11/2019
4	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 03/2006
4	Tumor Suppressor Protein p14ARF (p14ARF)IBA 06/2020 - 01/2017
4	Ifosfamide FDA LinkGeneric 05/2018 - 10/2009
4	Messenger RNA (mRNA)IBA 04/2018 - 08/2011
3	Therapeutic UsesIBA 01/2024 - 07/2015
3	tremelimumabIBA 01/2024 - 11/2019
3	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2005
3	pembrolizumabIBA 01/2023 - 01/2021
3	B7-H1 AntigenIBA 01/2022 - 11/2019
3	Hemoglobins (Hemoglobin)IBA 09/2020 - 01/2014
3	squamous cell carcinoma-related antigenIBA 11/2019 - 09/2007
3	Etoposide (VP 16)FDA LinkGeneric 05/2018 - 10/2008
3	CateninsIBA 01/2018 - 02/2014
2	VaccinesIBA 01/2024 - 01/2020
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 11/2019
2	cediranib (AZD2171)IBA 12/2023 - 10/2023
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2018
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 01/2017
2	Angiotensin Receptor AntagonistsIBA 04/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 10/2019 - 01/2015
2	Proton Pump InhibitorsIBA 07/2017 - 10/2015
2	Adenosine Triphosphatases (ATPase)IBA 07/2017 - 10/2015
2	Dynamin IIIBA 12/2016 - 08/2010
2	Annexin A4IBA 11/2016 - 06/2013
2	Losartan (Cozaar)FDA LinkGeneric 10/2014 - 07/2012
2	Angiotensin IIIBA 10/2014 - 07/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2014 - 03/2010
2	LectinsIBA 01/2013 - 04/2006
2	Laminin (Merosin)IBA 01/2013 - 08/2012
2	Galectin 1 (LGALS1)IBA 01/2013 - 08/2012
2	Eukaryotic Initiation Factor-4EIBA 03/2011 - 11/2005
2	retinoic acid receptor betaIBA 01/2011 - 09/2007
2	Topotecan (Hycamtin)FDA LinkGeneric 10/2010 - 08/2009

Therapy/Procedure

30	Drug Therapy (Chemotherapy) 04/2024 - 10/2008
27	Hysterectomy 03/2024 - 01/2010
21	Therapeutics 03/2024 - 10/2009
12	Radiotherapy 01/2023 - 07/2007
11	Laparotomy 01/2023 - 09/2009
9	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 06/2011
8	Combination Drug Therapy (Combination Chemotherapy) 01/2024 - 10/2008
6	Neoadjuvant Therapy 10/2023 - 01/2007
5	Cytoreduction Surgical Procedures 12/2023 - 09/2016
5	Minimally Invasive Surgical Procedures 10/2023 - 04/2015
5	Adjuvant Chemotherapy 01/2022 - 06/2007
4	Adjuvant Radiotherapy 01/2021 - 06/2012
4	Operative Time 10/2019 - 09/2010
3	Uterine Myomectomy 07/2021 - 06/2011
3	Ligation 07/2021 - 12/2013
3	Chemoradiotherapy 10/2020 - 11/2019
3	High-Intensity Focused Ultrasound Ablation 03/2016 - 05/2012
3	Trachelectomy 07/2015 - 06/2012
3	Length of Stay 01/2015 - 09/2010
3	Vaginal Hysterectomy 11/2012 - 07/2009
2	Colpotomy 03/2022 - 06/2011
2	Brachytherapy 07/2021 - 07/2007
2	Morcellation 07/2014 - 01/2010
2	Ovariectomy (Oophorectomy) 05/2012 - 07/2010
2	Consolidation Chemotherapy 12/2011 - 07/2007
2	Surgical Instruments (Clip) 06/2011 - 09/2009
2	Surgical Gloves (Surgical Glove) 01/2010 - 09/2009